We are proud to announce that Pathomics Health has passed all assessments by Association of Trade and Commerce (ATC) and have made it to the Singapore SME 500 Award 2025!
The assessment involves evaluating enterprises in its business standards and qualities, including the ability to further develop the business and scale its market.
The Singapore SME 500 Award 2025 is significant for Pathomics Health as it affirms our business standards, qualities and vision to offer our products and services regionally.
Being awarded the Singapore SME 500 Award is a big milestone for us and we will like to thank our partners, clients and most importantly Team Pathomics who have made this possible.
